bq 610 has been researched along with rubidium in 1 studies
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (rubidium) | Trials (rubidium) | Recent Studies (post-2010) (rubidium) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 5,163 | 18 | 269 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dibas, A; Hulet, C; Prasanna, G; Yorio, T | 1 |
1 other study(ies) available for bq 610 and rubidium
| Article | Year |
|---|---|
Inhibition of Na(+)/K(+)-atpase by endothelin-1 in human nonpigmented ciliary epithelial cells.
Topics: Antihypertensive Agents; Biological Transport; Bumetanide; Carrier Proteins; Cells, Cultured; Ciliary Body; Diuretics; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Oligopeptides; Ouabain; Peptides; Pigment Epithelium of Eye; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Receptor, Endothelin A; Receptor, Endothelin B; Rubidium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Time Factors | 2001 |